Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Masahiro Hirakawa"'
Autor:
Yasushi Sato, Kyoko Hamaguchi, Masahiro Hirakawa, Koshi Fujikawa, Yasuo Takahashi, Hiroyuki Nagashima, Eriko Waga, Tamotsu Sagawa
Publikováno v:
Journal of Clinical Oncology. 38:297-297
297 Background: An association between improved responses to chemotherapy after exposure to vaccine-based immunotherapy has been previously reported in other cancers. However, it is unclear whether the chemotherapy response improves after exposure to
Autor:
Masahiro Hirakawa, Eriko Waga, Yasuo Takahashi, Koshi Fujikawa, Tamotsu Sagawa, Hiroyuki Nagashima, Yasushi Sato, Kyoko Hamaguchi
Publikováno v:
Journal of Clinical Oncology. 38:298-298
298 Background: Stage IV Gastric cancer (GC) is a heterogeneous biological condition with a mixture of distant metastases, including hematologic, lymph nodal and/or peritoneal. In the recent classification introduced by Yoshida et al with the proposa
Autor:
Masahiro Hirakawa, Kyoko Hamaguchi, Hiroyuki Ohnuma, Koichi Okamoto, Hiroshi Miyamoto, Yasuo Takahashi, Tetsuji Takayama, Tamotsu Sagawa, Koshi Fujikawa, Naoki Muguruma, Yasushi Sato
Publikováno v:
Journal of Clinical Oncology. 36:174-174
174 Background: Although the triplet regimen of docetaxel/cisplatin/S-1 (DCS) has shown promising activity and conversion rate in patients with unresectable metastatic gastric cancer (UMGC) in Japan, it was accompanied by severe adverse events. Recen
Autor:
Masakazu Hori, Kazuyuki Murase, Masahiro Hirakawa, Koji Miyanishi, Tsuyoshi Hayashi, Takahiro Osuga, Koh-ichi Sakata, Masayoshi Kobune, Junji Kato, Hiroyuki Ohnuma, Tsutomu Sato, Rishu Takimoto, Yutaka Okagawa, Tetsuji Takayama, Yasushi Sato, Satoshi Iyama, Yutaka Kawano, Kohichi Takada, Masanori Someya, Tamotsu Sagawa
Publikováno v:
Journal of Clinical Oncology. 33:123-123
123 Background: Definitive chemoradiotherapy is one of the options for advanced esophageal cancer (AEC). However, AEC patient survival remains unsatisfactory. To investigate a regimen of definitive chemoradiotherapy that exerts good local control of
Autor:
Yasushi Sato, Shinich Katsuki, Masahiro Hirakawa, Tokunori Okuda, Tamotsu Sagawa, Tsuyoshi Hayashi, Koji Miyanishi, Kohichi Takada, Hiroyuki Ohnuma, Rishu Takimoto, Takahiro Osuga, Yasuo Takahashi, Takayuki Nobuoka, Tetsuji Takayama, Koichi Hirata, Junji Kato, Tsutomu Sato, Yasuhiro Sato, Masayoshi Kobune, Hiroshi Miyamoto
Publikováno v:
Journal of Clinical Oncology. 32:124-124
124 Background: Recently the efficacy of trastuzumab (T-mab) for HER2-positive gastric cancer has been reported. We have developed a triplet-drug combination regimen consisting of docetaxel, CDDP, and S-1 (DCS) and reported that the regimen provides
Autor:
Kohichi Takada, Masahiro Hirakawa, Koji Miyanishi, Masayoshi Kobune, Koichi Hirata, Kenji Okita, Yasushi Sato, Minoru Takahashi, Tomohisa Furuhata, Takahiro Osuga, Tsuyoshi Hayashi, Hiroyuki Ohnuma, Rishu Takimoto, Junji Kato, Tsutomu Sato
Publikováno v:
Journal of Clinical Oncology. 32:612-612
612 Background: In a recent study by Loupakis, F. et al. (ASCO-GI 2013), a FOLFOXIRI and bevacizumab regimen showed promising activity and conversion rate in patients (pts) with metastatic colorectal cancer (mCRC). In order to evaluate a treatment re